Structural modification of steroids by microorganisms, known since the 1950s, is nowadays a base for industrial production of many steroid hormones and their high-value precursors. Phytosterols, renewable biomaterials of plant origin, are recognised now as most attractive, low-cost and available raw materials for the pharmaceutical industry. 
IX, 3b-hydroxyandrost-5-en-17-one (dehydroepiandrosterone; prasterone, DHEA), by M. neoaurum VKM Ac-1815D using chemical protection/ deprotection of 3b-hydroxyl function; X, 3b,7a,15a-trihydroxyandrost-5-ene-17-one, by Fusarium graminearum and relative fungal strains; XII, 3b-hydroxy-5,7-diene-17-one, by bioconversion with 7b-hydroxylating fungal strain followed by chemical modification; XIII, androst-4-ene-3-one-17b-ol (testosterone), by engineered M. neoaurum strain; XIV, androst-1,4-diene-3-one-17b-ol, boldenone, by recombinant M. neoaurum strain.
In Focus representatives of Mycobacterium, Rhodococcus and Gordonia.
It was assumed that the mycolic acid rich cell wall of these Actinobacteria may contribute to the effective transportation of lipophilic substances such as steroids.
Actinobacteria are known to catabolise phytosterol via the 9(10)-secosteroid pathway 11 . Along with degradation of the aliphatic side chain, different modifications of the steroid core occur during sterol bioconversion, such as 3b-hydroxy-5-ene to 3-keto-4-ene moiety transformation, D1-dehydrogenation, 9a-hydroxylation.
Metabolic engineering allows overproduction of the valued steroids by exploiting the cascade reactions that are the part of the degradative pathway 12 .
We have developed microbial technologies based on phytosterol biotransformation by whole-cell actinobacteria, and especially, by Effective down-stream procedures provide high purity (over 96%) crystalline products and the overall yield of the target steroids is over 30% (w/w).
Based on the results of the full genome sequencing and genomewide transcriptomic profiling the specific genes and gene clusters, which are essential for steroid modifications have been revealed 13, 14 . The data were used for the generation of engineered strains with improved biocatalytic capabilities for production of AD (II), 20-hydroxymethyl pregn-4-ene-3-one (VII) and other value-added steroids ( Figure 1 ). The recombinant strains capable of single-step converting of phytosterol to testosterone (XIII), 1-dehydrotestosterone (XIV), progesterone (VIII) have been generated using heterologous expression of eukaryotic steroidogenic systems in mycobacterial hosts 15, 16 . Effective production of dehydroepiandrosterone (DHEA, IX) from phytosterol (I) has been provided by the combination of the chemical protectiondeprotection of the oxygen functionality at C3 with selective side chain degradation of the 3-substituted sterols using M. neoaurum (XII), which can be used in the syntheses of vitamin D3 derivatives.
Effective procedures for the isolation and purification have been developed which provide high (>96%) purity of the final crystalline products. The number of valued products that can be produced from phytosterol using our biotechnologies and active pharmaceutical ingredients (APIs) that can be synthesised from these steroidal products are presented in Figure 1 . 
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